#66 Seasoned Biotech Executive talks T-Cell Therapy and Running a Business in 2023!
BioTech IQ
by Ammon Rivera
9M ago
On this episode of BioTech IQ, Ammon interviews Paul Lammers the CEO of Triumvira about developing autologus cell therapies using their T-Cell Antigen Coupler Platform (TAC). During this insightful discussion Paul talks about how he started in the industry, running a biotech company in today's environment, and what sets Triumvira's T-Cell therapy apart from the rest! Don't miss it! Show support for show https://www.buymeacoffee.com/biotechiq Check out the books recommended by Paul: CEO Excellence - https://amzn.to/3OGjI3G The Emperor of All Maladies - https://amzn.to/3IDyZ1l The Physician ..read more
Visit website
#66 Seasoned Biotech Executive talks CART and Running a Business in 2023!
BioTech IQ
by Ammon Rivera
9M ago
On this episode of BioTech IQ, Ammon interviews Paul Lammers the CEO of Triumvira about developing autologus cell therapies using their T-Cell Antigen Coupler Platform (TAC). During this insightful discussion Paul talks about how he started in the industry, running a biotech company in today's environment, and what sets Triumvira's T-Cell therapy apart from the rest! Don't miss it! Show support for show https://www.buymeacoffee.com/biotechiq Check out the books recommended by Paul: CEO Excellence - https://amzn.to/3OGjI3G The Emperor of All Maladies - https://amzn.to/3IDyZ1l The Physician ..read more
Visit website
#65. A Journey From Investment Banker To The CEO Of A Biotech Developing Cancer Therapy With Bryan Kobel
BioTech IQ
by Ammon Rivera
10M ago
Bryan Kobel decided to pursue a career in biotech after seeing its massive opportunities to change the world. He sits down with Ammon Rivera to share how he translated his background as an investment banker into his role as the CEO of TC BioPharm, a company that develops cancer therapy. He opens up about finding his purpose in this space that allows him to save lives and molds him into a compassionate leader. Bryan also talks about their allogenic Gamma Delta T Cell therapy platform, which involves injecting isolated Gamma Delta T Cells to treat cancer-stricken patients. He explains how they a ..read more
Visit website
#65. A Journey From Investment Banker To The CEO Of A Biotech Developing Cancer Therapy With Bryan Kobel
BioTech IQ
by Ammon Rivera
11M ago
Bryan Kobel decided to pursue a career in biotech after seeing its massive opportunities to change the world. He sits down with Ammon Rivera to share how he translated his background as an investment banker into his role as the CEO of TC BioPharm, a company that develops cancer therapy. He opens up about finding his purpose in this space that allows him to save lives and molds him into a compassionate leader. Bryan also talks about their allogenic Gamma Delta T Cell therapy platform, which involves injecting isolated Gamma Delta T Cells to treat cancer-stricken patients. He explains how they a ..read more
Visit website
#64 A Professional Recruiters Perspective on The State of Hiring in Biotech!
BioTech IQ
by Ammon Rivera
1y ago
In this episode of BioTech IQ Ammon shares some real stats on the state of the hiring market in Biotech/pharma. We discuss what both job seekers and hiring managers can do to increase their success when searching/hiring. Bringing innovative treatments that make a difference in the life of people is the goal but the business side of drug development is as complex as the science sometimes. Don't miss it! Leave a review and share! Thanks! https://thebiotechiqpodcast.com/ Check me out on LinkedIn https://www.linkedin.com/in/ammonr ..read more
Visit website
#63 From writing a newspaper column at age 7 to becoming a BioTech CEO: Cary Claiborne Sr.
BioTech IQ
by Ammon Rivera
1y ago
Cary Claiborne Sr. is the CEO of Adial Pharmaceuticals and member of the board. He also sits on the board for Nuerosense Therapeutics and CytRx. Cary holds an MBA from Villanova University. In this episode Cary shares how his interest in finance at an early age led him to become the CFO of a small biotech that led him to where he is today. Books that Cary referenced: Holy Bible - https://amzn.to/3Y6um4W Control Your Destiny or Someone Else Will - https://amzn.to/3ITDuWc Check me out on LinkedIn https://www.linkedin.com/in/ammonr ..read more
Visit website
#62 From writing a newspaper column at age 7 to becoming a BioTech CEO: Cary Claiborne Sr.
BioTech IQ
by Ammon Rivera
1y ago
Cary Claiborne Sr. is the CEO of Adial Pharmaceuticals and member of the board. He also sits on the board for Nuerosense Therapeutics and CytRx. Cary holds an MBA from Villanova University. In this episode Cary shares how his interest in finance at an early age led him to become the CFO of a small biotech that led him to where he is today. Books that Cary referenced: Holy Bible - https://amzn.to/3Y6um4W Control Your Destiny or Someone Else Will - https://amzn.to/3ITDuWc Check me out on LinkedIn https://www.linkedin.com/in/ammonr ..read more
Visit website
#62 Biotech Consultant Shares Her Thoughts on Where We are Headed: It's About Innovation!
BioTech IQ
by Ammon Rivera
1y ago
On this episode of BioTech IQ Ammon interviews Farahnaz Forozan, PhD, MB who is a 20 year veteran in the industry. She discussed how she immigrated from Iran to the United States, became a Phd, was the Head of Translational Development with BMS, to running her own consulting practice. She has taken all this experience and is driving innovation within biotech. Don't miss it! It's about Innovation. www.forozanoncogenconsulting.com https://thebiotechiqpodcast.com/ Check me out on LinkedIn https://www.linkedin.com/in/ammonr ..read more
Visit website
#61 Tunable Radio Pharmaceuticals? The Founders of Ratio Therapeutics.
BioTech IQ
by Ammon Rivera
1y ago
Throughout many of the discussions on BioTech IQ it is clear that a combination of therapies is likely the answer to treating cancers and other diseases. This is a point well made by the guests on this episode of the show. CEO Jack Hoppin, PhD and Chief Scientific Officer, John Babich PhD are Co-Founders of Ratio Therapeutics. Both bring a successful background in biotech and not only discuss what their organization is doing but lessons they have learned as entrepreneurs in treatment development.  Don't miss it! https://thebiotechiqpodcast.com Don't forget to check out the YouTube Chan ..read more
Visit website
#60 Biotech Chief People Officer Discusses How To Build Company Culture
BioTech IQ
by Ammon Rivera
1y ago
Science will only get you so far in biotech. No matter how ingenious your products are, you will never succeed as a company if you don’t have all the pieces if business development in place. And there is no greater piece than the people piece. As the Chief People Officer of Biomea Fusion, Naomi Cretcher knows that company culture is what is going to make or break her company’s success. Despite everything that went on with COVID and with a recession looming, Naomi is confident that investing on their talent pool with pay off in terms of company success. She joins Ammon Rivera in this episode to ..read more
Visit website

Follow BioTech IQ on FeedSpot

Continue with Google
Continue with Apple
OR